Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Immunogenetics of Heparin-Induced Thrombocytopenia: Aim 2

NCT02526485 is registered in ClinicalTrials.gov with Vanderbilt University Medical Center as lead sponsor.

NCT NCT02526485
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02526485 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Immunogenetics of Heparin-Induced Thrombocytopenia: Aim 2
Lead sponsor
Vanderbilt University Medical Center
Phase
Observational
Overall status
Completed
Start date
March 31, 2015
Completion date
September 5, 2018
Enrollment
15 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

heparin-induced thrombocytopenia